System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Prof Olivier Huttin is an expert in Cardiology at Centre Hospitalier Universitaire de Nancy (France). As of October 2026, ScienceLeadR ranks Olivier Huttin in the top 1% of experts in France for Heart Valve Prolapse and Machine Learning. Olivier Huttin has authored 263 publications, the most recent in 2026, and is an investigator in 20 clinical trials, 7 of them ongoing. SLR score: 869 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Olivier Huttin Centre Hospitalier Universitaire de Nancy France
869 ScienceLeadR Reputation 869

Unlock

Register Login
Network Map

Cardiology

Subspecialties: Public Health - Nuclear Medicine - Medical Imaging

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2008 - 2026
Source: PubMed

Centre Hospitalier Universitaire de Nancy

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 263

Citations

Citations: 7 630 1st author: 30 Last author: 20 Unique author: 0

Main journals

Arch Cardiovasc Dis 23
Archives of Cardiovascular Diseases Supplements 21
EUR HEART J-CARD IMG 16
Eur Heart J 15
Archives of cardiovascular diseases. Supplements 9

Best Journals

Eur Heart J 8
Circulation 2
N Engl J Med 2

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Rivaroxaban for Stroke Prevention in Hypertrophic Cardiomyopathy Without Atrial Fibrillation and With Impaired Left Atrial Reservoir Strain: Design and Rationale of the LA-HCM Randomized Trial.
PMID 42844166 — stroke, rivaroxaban, atrial fibrillation, cardiomyopathy, hypertrophic, cardiomyopathies		Eur Heart J Cardiovasc Imaging20260
Contemporary Surgical Outcomes and Repair Rates in Degenerative Mitral Regurgitation: Real World Insights from the International MITRACURE Registry.
PMID 42092496 — registries, mortality, thoracic surgery, early intervention, educational, cardiovascular diseases, hospital mortality, mitral valve insufficiency		J Thorac Cardiovasc Surg20260
18F-Florbetaben PET Detection of Cardiac and Multi-Organ Involvement for Identifying AL and ATTR Cardiac Amyloidosis.
PMID 41906613 — lung, blood, salivary glands, multiple chronic conditions, amyloidosis, amyloid, transthyretin amyloidosis		JACC Adv20260
Machine-learning approach on echocardiography to improve the detection of transthyretin amyloid cardiomyopathy: GRAAL algorithm.
PMID 41883734 — prealbumin, algorithms, machine learning, echocardiography, amyloid, learning, cardiomyopathies, transthyretin amyloid cardiomyopathy		Eur Heart J Digit Health20260
Comparative diagnostic performance of machine learning models and traditional scores for HFpEF in older adults.
PMID 41859834 — heart failure, heart failure, diastolic, algorithms, machine learning, learning		Eur J Heart Fail20261

Clinical Studies 20

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

N/A 17
Phase 3 2
Phase 3/Phase 4 1

By status:

Completed 12
Recruiting 6
Active not recruiting 1
Not yet recruiting 1

By type:

Interventional 11
Observational 9

By Monocentric/Multicentric:

monocentric 13
multicentric2to4 3
multicentric5to9 0
multicentricup10 4

Main Topics

Cohort/Consortium Investigators 6

Ongoing Clinical Trials

7 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
LA HCM Rivaroxaban for Antithrombotic Prevention in Hypertrophic Cardiomyopathy Patients with Abnormal Left Atrial Strain A Randomized Multicenter Trial
2024-511084-28-00 — rivaroxaban, cardiomyopathy, hypertrophic, cardiomyopathies		Phase 3/Phase 4Recruiting2026
LA HCM Study Rivaroxaban for Antithrombotic Prevention in Hypertrophic Cardiomyopathy Patients With Abnormal Left Atrial Strain
NCT07202897 — anticoagulants, stroke, rivaroxaban, cardiomyopathy, hypertrophic, therapeutics, cardiomyopathies		Phase 3Recruiting2026
PAtient Treatment Analysis Hospital and Wide ranging Out of hospital Care Assessment Yields Insights Into Heart Failure Outcomes
NCT06338878 — heart failure, heart, therapeutics		N/ARecruiting2024
Machine Learning Approach Based on Echocardiographic Data to Improve Prediction of Cardiovascular Events in Hypertrophic Cardiomyopathy
NCT06256913 — hypertrophy, cardiomyopathy, hypertrophic, machine learning, learning, cardiomyopathies		N/ARecruiting2023
In depth ECG Analysis for the Extraction of Biomarkers of Cardiac Mechanical Dispersion
NCT06163911 — pathology, biomarkers, echocardiography, electrocardiography		N/ANot yet recruiting2023

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS